Feasibility Study of Adjuvant Chemotherapy with Carboplatin and Nab-Paclitaxel for Completely Resected NSCLC.
Katsurada N, Tachihara M, Hatakeyama Y, Koyama K, Yumura M, Kiriu T, Dokuni R, Hazama D, Tokunaga S, Tamura D, Nakata K, Yamamoto M, Kamiryo H, Kobayashi K, Tanaka Y, Maniwa Y, Nishimura Y.
Katsurada N, et al. Among authors: yumura m.
Cancer Manag Res. 2020 Feb 3;12:777-782. doi: 10.2147/CMAR.S239647. eCollection 2020.
Cancer Manag Res. 2020.
PMID: 32099473
Free PMC article.